ITRM - Iterum Therapeutics plc

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-43,526
-44,434
-91,564
-52,006
-103,130
Depreciation & amortization
3,134
1,800
2,104
161
152
Stock based compensation
6,268
4,758
4,319
2,759
2,173
Change in working capital
-235
2,311
-440
-24,556
17,899
Accounts Payable
954
1,895
63
-14,671
11,446
Other working capital
-16,697
-18,535
-15,903
-54,539
-78,909
Other non-cash items
5,651
5,383
8,139
17,709
4,146
Net cash provided by operating activites
-16,667
-18,473
-15,842
-54,528
-78,885
Cash flows from investing activities
Investments in property, plant and equipment
-30
-62
-61
-11
-24
Purchases of investments
-42,984
-45,708
-67,034
0
0
Sales/Maturities of investments
48,127
59,727
12,500
0
40,125
Net cash used for investing activites
5,113
13,957
-54,595
-11
40,101
Cash flows from financing activities
Debt repayment
-3,880
-2,251
-6,516
-6,233
-1,034
Common stock issued
0
433
89,643
69,964
0
Net cash used privided by (used for) financing activities
-3,880
-1,818
83,127
64,475
-974
Net change in cash
-15,493
-6,384
12,694
9,925
-39,780
Cash at beginning of period
36,046
27,510
14,816
4,891
44,671
Cash at end of period
20,612
21,126
27,510
14,816
4,891
Free Cash Flow
Operating Cash Flow
-16,667
-18,473
-15,842
-54,528
-78,885
Capital Expenditure
-30
-62
-61
-11
-24
Free Cash Flow
-16,697
-18,535
-15,903
-54,539
-78,909